Suppr超能文献

杀菌/通透性增加蛋白(rBPI23)的重组23 kDa N端片段可降低免疫抑制相关中性粒细胞减少期间大肠杆菌诱导的死亡率和器官损伤。

The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia.

作者信息

Lechner A J, Lamprech K E, Johanns C A, Matuschak G M

机构信息

Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, Missouri 63104-1028, USA.

出版信息

Shock. 1995 Oct;4(4):298-306. doi: 10.1097/00024382-199510000-00012.

Abstract

Cyclophosphamide-induced neutropenia exacerbates septic shock and multiple organ injury in conscious rats during Escherichia coli (EC) bacteremia despite antibiotics and fluid administration. We hypothesized that such shock and inflammatory organ injury would be mitigated by rBPI23's microbicidal activity and/or binding of EC endotoxins. Four days after 100 mg cyclophosphamide/kg, catheterized rats with < 300 PMNs/microL were pretreated with rBPI23 or the irrelevant 22 kDa protein thaumatin [3.3-6.6 mg/kg, i.v. in 0.9% NaCl (NS)] 5 min before graded i.v. infection with 5 x 10(9) or 1 x 10(10) cfu of EC serotype 055:B5 ending at t = 0. Posttreatment with each protein continued (3.3-6.6 mg/kg in 1 mL NS/h) through 8 h, in addition to penicillin plus amikacin sulfate at t = 1.5 and 8 h. Arterial samples were obtained before pretreatment and at t = 1.5, 4.5, 8, and 24 h when animals were necropsied. One of eight thaumatin + 5 x 10(9) EC rats and none of six thaumatin + 10(10) EC rats survived 24 h. In contrast, rBPI23 significantly reduced mortality after either inoculum, improved bacterial clearance, and led to renormalization of early EC-induced hypotension, hypothermia, tachypnea, hyperoxemia, and hypocarbia. Compared with thaumatin, however, rBPI23 did not reduce circulating endotoxin or bioactive and antigenic tumor necrosis factor-alpha. Sepsis-induced severe neutropenia (< 50 PMNs/microL) evident in all EC rats by t = 1.5 h was reversed with rBPI23 by t = 8 h, but thrombocytopenia (< 5 x 10(4) platelets/microL) evident in all groups by t = 4.5 h was not altered.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

环磷酰胺诱导的中性粒细胞减少症会加剧清醒大鼠在大肠杆菌(EC)菌血症期间的感染性休克和多器官损伤,即便给予了抗生素和液体治疗。我们推测,rBPI23的杀菌活性和/或与EC内毒素的结合可减轻此类休克和炎症性器官损伤。在给予100mg/kg环磷酰胺4天后,对导管插入且中性粒细胞计数<300个/微升的大鼠,在静脉内分级感染5×10⁹或1×10¹⁰cfu的EC血清型055:B5(感染在t = 0时结束)前5分钟,用rBPI23或不相关的22kDa蛋白质奇异果甜蛋白[3.3 - 6.6mg/kg,静脉注射于0.9%氯化钠(NS)中]进行预处理。每种蛋白质的治疗后持续给药(3.3 - 6.6mg/kg于1mL NS/h中)至8小时,此外在t = 1.5小时和8小时给予青霉素加硫酸阿米卡星。在预处理前以及动物尸检时的t = 1.5、4.5、8和24小时采集动脉样本。8只接受奇异果甜蛋白 + 5×10⁹EC的大鼠中有1只存活24小时,6只接受奇异果甜蛋白 + 10¹⁰EC的大鼠均无存活24小时。相比之下,rBPI23显著降低了两种接种量后的死亡率,改善了细菌清除,并使早期EC诱导的低血压、体温过低、呼吸急促、高氧血症和低碳酸血症恢复正常。然而,与奇异果甜蛋白相比,rBPI23并未降低循环内毒素或生物活性及抗原性肿瘤坏死因子-α。到t = 1.5小时时,所有EC大鼠中明显出现的脓毒症诱导的严重中性粒细胞减少症(<50个/微升)在t = 8小时时被rBPI23逆转,但到t = 4.5小时时所有组中明显出现的血小板减少症(<5×10⁴个/微升)未改变。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验